Table 6

Predictors of Angiographic Restenosis and Clinical Outcomes on Multivariate Analysis

Odds Ratio95% Confidence Intervalp Value
Angiographic restenosis
 Sirolimus-eluting stent0.150.06–0.400.0001
 Cilostazol0.320.11–0.890.029
 Lesion length1.031.01–1.060.013
 Post-procedural MLD0.170.05–0.280.005
Target lesion revascularization
 Sirolimus-eluting stent0.240.07–0.810.021
 Cilostazol0.260.07–0.950.042
Major adverse cardiac events
 Sirolimus-eluting stent0.210.06–0.710.012

MLD = minimal lumen diameter.